Citeline

Citeline Clinical provides comprehensive real-time R&D intelligence to the life sciences industry, featuring an unmatched collection of global clinical trials data, vetted investigators, trial sites and drug development pipelines. Our content is curated by the industry’s largest team of expert analysts, making Citeline Clinical an unparalleled source of R&D intelligence. The Biomarker Target or Mechanism of Action + Real World Data (RWD) data package provides a comprehensive dataset to evaluate and analyze the competitive landscape of a clinical trial, and trial details, within a particular biomarker target or mechanism of action.

It pulls together the most relevant data points from the Pharmaprojects, Trialtrove, and Sitetrove data sources, and surfaces insights into various aspects of drug evaluation, clinical trials, and benchmarks from over the past five years. Additionally, the packages includes patient claims and diversity data from over the past two years. gov; data is constantly curated from over 58,000 unique sources and the number of sources per TA has increased by ~40% since 2015 The clinical trial record is further populated by our Analyst team using supplementary sources and enriched with custom tagging to classify and categorize patient segments, trial tags/attributes, outcomes and more.

• 430,000+ trials (phases I-IV) • 58,000+ data sources • 3,400+ patient segments • 1,350+ endpoints • 310+ diseases across 9 therapeutic areas • 200+ countries in all geographic areas Sitetrove features 550,000+ investigators from 194,000+ sites across 185+ countries to accelerate trial planning and execution. 1M+ HCPs, and 98% of Payers. The following sets of data have been included in this listing: Trials – By Biomarker Target Biomarkers -By Synonyms Biomarkers – By Utility Trials - By Therapeutic Area, Disease, Patient Segment Trials - Details by Phase, Status, and Benchmarks for Sites/Patients Trials - By Country/Region Trials - By Drug Trials - By Sponsors Trials - By Tags/Attributes Trials - By Outcomes Trials - By Study Design Attributes Trials - by Primary Endpoints Trials - Benchmarks by Patients per Site per Month per Sponsor Trials - Benchmarks by Patients per Site per Month per Disease Trials - Benchmark Sites per Country Drugs - By Company, Status Drugs - By Mechanism of Action Drugs - By Biological Target Drugs - By Therapeutic Class Disease - By ICD10 Codes Investigator – Investigator Contact Details Investigator – By Trial Investigator – By Site Investigator – By Affiliated Site Investigator – By Sponsor Investigator – By Specialty Investigator – By Network Investigator – By Tier Site - Site Location Details Site - By Trial Site - By NPI Site - By Sponsor Relationship Site - By Hierarchy Includes additional data from the Real World Data asset: Investigator - Patient Landscape Site - Patient Landscape Investigator - Patient Diversity Site - Patient Diversity HCP - Profiles HCP - Patient Diversity You can use this data to analyze trends, make predictions, and inform your decision-making process in the pharmaceutical industry.

Once you subscribe to this listing, you will have access to all the data tables required. Workflow: • Consumer clicks “Request” on Citeline listing; • Citeline will reach out to the consumer and finalize terms; • Citeline shares the data package with the consumer via Snowflake shares. Additional Information: This data package is updated regularly to ensure that you have the most recent and accurate information.

If you have any questions or need further information, please don’t hesitate to contact us.